Trials / Sponsors / OrphAI Therapeutics
OrphAI Therapeutics
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | A Phase 2a Study of LAM-001 for the Treatment of Pulmonary Hypertension Pulmonary Hypertension | Phase 2 | 2023-04-03 |
| Completed | Study of Safety, Tolerability, and Biological Activity of LAM-002A in C9ORF72-Associated Amyotrophic Lateral S Amyotrophic Lateral Sclerosis, ALS | Phase 2 | 2021-12-23 |
| Completed | A Study of LAM-002A for the Prevention of Progression of COVID-19 COVID-19 Disease | Phase 2 | 2020-07-15 |
| Completed | A Study of LAM-003 in Patients With Acute Myeloid Leukemia Oncology, Acute Myeloid Leukemia | Phase 1 | 2018-01-16 |
| Completed | A Phase I Dose Escalation Study of the Safety and Pharmacokinetics of LAM-002A In Patients With Non-Hodgkin's Lymphoma, Non-Hodgkin; Leukemia, Chronic Lymphocytic | Phase 1 | 2015-10-01 |
| No Longer Available | An Open-Label, Expanded Access Protocol of LAM-002A in C9ORF72-Associated Frontotemporal Dementia (FTD) Frontotemporal Dementia | — | — |